13.00 USD
▼-0.16-1.22%
盘后 13.99 0.00%
2026-09-15
市值
$1.11B
市盈率
16.88
EPS
0.78
股息率
—
52 周区间
6.26 – 15.89
成交量
463.36K
Beta
0.65
目标价
17.60
52W 低 6.2652W 高 15.89
价格走势
公司简介
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a ...